Volume 20, Number 7—July 2014
Highlight and copy the desired format.
|EID||Artemisinin. Emerg Infect Dis. 2014;20(7):1217. https://dx.doi.org/10.3201/eid2007.et2007|
|AMA||Artemisinin. Emerging Infectious Diseases. 2014;20(7):1217. doi:10.3201/eid2007.et2007.|
|APA||(2014). Artemisinin. Emerging Infectious Diseases, 20(7), 1217. https://dx.doi.org/10.3201/eid2007.et2007.|
Artemisinin is an antimalarial lactone derived from qing hao (Artemisia annua or sweet wormwood). The medicinal value of this plant has been known to the Chinese for at least 2,000 years. In 1596, Li Shizhen recommended tea made from qing hao specifically to treat malaria symptoms. The genus name is derived from the Greek goddess Artemis and, more specifically, may have been named after Queen Artemisia II of Caria, a botanist and medical researcher in the fourth century
- Artemisia II. Encyclopaedia Britannica Online [cited 2014 Apr 17]. http://www.britannica.com/EBchecked/topic/36829/Artemisia-II.
- Dorland’s illustrated medical dictionary. 32nd ed. Philadelphia: Elsevier Saunders; 2012.
- Vinetz JM, Clain J, Bounkeua V, Eastman RT, Fidock D. Chemotherapy of malaria. In: Brunton LL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: The McGraw-Hill Companies, Inc; 2011. p. 1383–418.
- Page created: June 17, 2014
- Page last updated: June 17, 2014
- Page last reviewed: June 17, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)